Asilomed

Manufacturing of intraocular lenses and surgical knives for the ophthalmic industry.

About Asilomed

Asilomed is a Healthcare company. Manufacturing of intraocular lenses and surgical knives for the ophthalmic industry. Its Indian entity Asilomed Private Limited reported revenue of β‚Ή13.42 Cr. Asilomed offers products and services including Intraocular Lenses and Micro Surgical Blades. Its focus areas include Pharmaceuticals, Ophthalmic Solutions, Surgical Aids and Medical Devices.

Company details

Asilomed Private Limited is recognized as a key manufacturer in the ophthalmic medical device sector, where intraocular lenses and surgical knives are produced to address vision impairments. These products are crafted using imported, certified medical grade materials to ensure biocompatibility and adherence to international standards. The company operates with advanced infrastructure certified by regulatory bodies, facilitating bulk production and participation in global events. Its focus on precision engineering supports cataract surgeries and other procedures, enhancing patient outcomes without promotional emphasis. Infrastructure includes high-precision machines and clean rooms, contributing to reliable supply in the industry.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website asilomed.com
  • Legal Name Asilomed Private Limited
  • Date of Incorporation 03 Oct, 2020
  • Jurisdiction Hosur, Tamil Nadu, India
Operational Areas
Key Metrics
  • Indian entity revenue
    ₹13.42 Cr

    FY 2025 · +92% YoY

  • Indian entity net profit
    ₹8.5 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹1.93 Cr

    FY 2025 · 14% margin

Products & Services of Asilomed

Asilomed offers a comprehensive portfolio of products and services, including Intraocular Lenses and Micro Surgical Blades.

Intraocular Lenses
Medical Devices

Intraocular lenses are designed to replace natural lenses in the eye, assisting patients with cataracts or vision issues through precision crafting with advanced materials.

Micro Surgical Blades
Surgical Instruments

Micro surgical blades are produced for ophthalmic procedures, utilizing imported raw materials to support various surgical needs in the industry.

Board of directors of Asilomed Private Limited (Asilomed)

Asilomed Private Limited is the primary company behind Asilomed. The board of Asilomed Private Limited currently have 6 directors; the longest-serving is Ramalingam Ravikumar, appointed in 2020. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Ramalingam Ravikumar
DIN 07879765
Director03 Oct 20206 yrs 1 moAsilomed Private Limited
Rajagopal Duraisamy
DIN 08905810
Director06 Oct 20206 yrs 1 moAsilomed Private Limited
Govindasamy Dharmalingam
DIN 08491958
Director08 Aug 20233 yrs 3 moAsilomed Private Limited
Vingnanamurthy Silambarasan
DIN 08491959
Director08 Aug 20233 yrs 3 moAsilomed Private Limited
Mohammed Farook Yasar Arabath
DIN 10270196
Director08 Aug 20233 yrs 3 moAsilomed Private Limited
Elangoveera Balakrishnan
DIN 03174160
Additional Director06 Aug 20251 yr 3 moAsilomed Private Limited

Financials of Asilomed

Figures of Asilomed Private Limited, the primary company behind Asilomed, for FY 2025. Revenue was ₹13.42 Cr (+92% year on year). Net profit was ₹8.5 Lakh (1% margin). EBITDA was ₹1.93 Cr (14% margin). Revenue has grown at a compounded annual rate of +917% over three years.

  • ₹13.42 CrRevenue · FY 2025 · +92% YoY
  • ₹8.5 LakhNet profit · 1% margin
  • ₹1.93 CrEBITDA · 14% margin
  • ₹3.50 CrPaid-up capital
  • 15Employees (provident fund records)
  • +917%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Asilomed Private Limited are on its company page.

Premium access

Detailed financial statements for Asilomed

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Asilomed

The primary company behind Asilomed, Asilomed Private Limited, reported revenue of β‚Ή13.42 Cr for FY 2025, up 92% year on year.

Asilomed Private Limited is recognized as a key manufacturer in the ophthalmic medical device sector, where intraocular lenses and surgical knives are produced to address vision impairments. These products are crafted using imported, certified medical grade materials to ensure biocompatibility and adherence to international standards. The company operates with advanced infrastructure certified by regulatory bodies, facilitating bulk production and participation in global events. Its focus on precision engineering supports cataract surgeries and other procedures, enhancing patient outcomes without promotional emphasis. Infrastructure includes high-precision machines and clean rooms, contributing to reliable supply in the industry.

Asilomed offers Intraocular Lenses and Micro Surgical Blades.

Asilomed operates through Asilomed Private Limited.

The legal entities of Asilomed currently have 6 directors, including Ramalingam Ravikumar, Rajagopal Duraisamy, Elangoveera Balakrishnan and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available